Clinical Trial Update: Nanochip Technology in Monitoring Treatment Response and Detecting Relapse in Participants With Diffuse Large B-Cell Lymphoma [NA]

View source ↗

Summary

This clinical trial update describes the use of nanochip technology to monitor treatment response and detect relapse in participants with diffuse large B-cell l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• High-grade B-cell Lymphoma

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Diffuse Large B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type | NA | Status: ACTIVE_NOT_RECRUITING